Poster | Regulatory requirements for GMO applications

June 23, 2023

In the EU, a GMO is defined as an organism in which the genetic material has been altered in a way that does not occur naturally by mating and/or natural recombination.

Have look at the poster that ASPHALION experts prepared for the SETGYC congress about the “Regulatory requirements for genetically modified organism (GMO) applications: tips and tricks for global ATMP and vaccine development”.

Asphalion has participated in the following research projects funded by the European Union’s Horizon 2020 Research and Innovation programme: MISTRAL-HIV (No 847943), CardioReGenix (No 825670), RBDCOV (No 101046118), and UroPrint (No  964883); and on the Innovative Medicines Initiative 2 Joint Undertaking project ARDAT (No 945473), and on the Eurostars project Synchropace (ref. 115484 through the Innovative UK Project 600538).

VIEW THE POSTER HERE

For further information contact us at: [email protected]

Search News & Events

  • Filter by category

Share

Related news and events

HORIZON EUROPE | GreenNanoBone KoM

This European-funded project aims to develop a treatment for medication-related osteonecrosis of the jaw (MRONJ) using sustainable, biocompatible, bioactive, and antimicrobial 4D materials derived from food waste.

HORIZON EUROPE | PreKoM GreenNanoBone

Yesterday, we celebrated the Pre-Kick off Meeting for the new GreenNanoBone project at our Barcelona offices. Alongside project coordinator Kasia Gurzawska, Asphalion experts Maria Castellà

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting